Trial ID or NCT#

NCT01020812

Status

not recruiting iconNOT RECRUITING

Purpose

To determine the efficacy and toxicity of TACE combined with SBRT

Official Title

Phase II Study of Combination Stereotactic Body Radiotherapy (SBRT) With Transarterial Chemo-Embolization (TACE) for Unresectable Hepatocellular Carcinoma

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Daniel Chang
Daniel Chang
Radiation oncologist
Sue and Bob McCollum Professor
Aya Kamaya, MD
Aya Kamaya, MD
Radiologist
Professor of Radiology (Body Imaging)
Brendan C. Visser, MD
Brendan C. Visser, MD
Hepatobiliary surgeon, Pancreatic surgeon, Surgical oncologist
Associate Professor of Surgery (General Surgery)
George A. Fisher Jr.
George A. Fisher Jr.
Medical oncologist, Gastrointestinal specialist
Colleen Haas Chair in the School of Medicine
Daniel Sze, MD, PhD
Daniel Sze, MD, PhD
Interventional radiologist
Professor of Radiology (Interventional Radiology)
Nishita Kothary, MD
Nishita Kothary, MD
Interventional radiologist
Professor of Radiology (Interventional Radiology)
Lawrence "Rusty" Hofmann, MD
Lawrence "Rusty" Hofmann, MD
Interventional radiologist
Professor of Radiology (Interventional Radiology)
Samuel So, MD
Samuel So, MD
Surgical oncologist, Liver surgeon, General surgeon
Lui Hac Minh Professor in the School of Medicine

Contact us to find out if this trial is right for you.

CONTACT

Ccto-office@stanford.edu
(650) 498-7061